Back to Search
Start Over
Improvement in patient‐reported "taste" and association with smell in dupilumab‐treated patients with severe chronic rhinosinusitis with nasal polyps from the SINUS‐24 and SINUS‐52 trials.
- Source :
-
Clinical & Experimental Allergy . Sep2022, Vol. 52 Issue 9, p1105-1109. 5p. 2 Charts. - Publication Year :
- 2022
-
Abstract
- In conclusion, our analysis shows that in patients with severe CRSwNP, dupilumab treatment improved patient-reported "taste" versus placebo. Sense of smell was measured using the loss-of-smell score (LoS) - reported daily by patients on a scale of 0-3, similar to how patient-reported taste was measured - UPSIT and the SNOT-22 smell/taste item. Improvement in patient-reported "taste" and association with smell in dupilumab-treated patients with severe chronic rhinosinusitis with nasal polyps from the SINUS-24 and SINUS-52 trials Post-hoc analysis showed dupilumab significantly improves patient-reported "taste" versus placebo in patients with severe CRSwNP. [Extracted from the article]
- Subjects :
- *SMELL disorders
*NASAL polyps
*SMELL
*SINUSITIS
*OLFACTOMETRY
Subjects
Details
- Language :
- English
- ISSN :
- 09547894
- Volume :
- 52
- Issue :
- 9
- Database :
- Academic Search Index
- Journal :
- Clinical & Experimental Allergy
- Publication Type :
- Academic Journal
- Accession number :
- 158810089
- Full Text :
- https://doi.org/10.1111/cea.14194